References

medsovet

Медицинский Совет

Meditsinskiy sovet = Medical Council

2079-701X2658-5790

REMEDIUM GROUP Ltd.

10.21518/ms2023-309

medsovet-7810

Research Article

COVID-19

Сердечно-сосудистые осложнения в контексте COVID-19: нарушения ритма сердца

Cardiovascular complications in the context of COVID-19: arrhythmias

https://orcid.org/0000-0002-6665-8601

Змитрукевич

А. С.

Zmitrukevich

A. S.

Змитрукевич Андрей Станиславович - ассистент кафедры пропедевтики внутренних болезней ЛФ, РНИМУ имени Н.И. Пирогова; врач общей практики (семейный врач), ГП №11 Департамента здравоохранения города Москвы.

117997, Москва, ул. Островитянова, д. 1; 119331, Москва, ул. Кравченко, д. 14

Andrei S. Zmitrukevich - Assistant of the Department of Propaedeutics of Internal Diseases of the Faculty of General Medicine, Pirogov RNRMU; Family Medicine Physician, CP No. 11.

1, Ostrovityanov St., Moscow, 117997; 14 Kravchenko St., Moscow, 119331

andrey1881889@gmail.com

https://orcid.org/0000-0001-9183-3216

Мамедова

А. Е.

Mamedova

A. E.

Мамедова Анастасия Евгеньевна, ассистент кафедры биологической химии, Гродненский государственный медицинский университет;

230009, Беларусь, Гродно, ул. Горького, д. 81

Anastasiya E. Mamedova - Assistant of the Department of Biochemistry.

81, Gorky St., Grodno, 230009

kopats_93@mail.ru

https://orcid.org/0000-0001-7479-418X

Резник

Е. В.

Reznik

E. V.

Резник Елена Владимировна, доктор медицинских наук, профессор, заведующая кафедрой пропедевтики внутренних болезней ЛФ, ведущий научный сотрудник НИЛ ревматических заболеваний, РНИМУ имени Н.И. Пирогова; врач-терапевт, кардиолог, врач функциональной диагностики, врач УЗИ, ГКБ №31 имени академика Г.М. Савельевой; Researcher ID: N-6856-2016

117997, Москва, ул. Островитянова, д. 1; 119415, Москва, ул. Лобачевского, д. 42, стр. 1

Elena V. Reznik - Dr. Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Diseases of the Faculty of General Medicine, Leading Researcher at the Rheumatic Diseases Research Laboratory; Pirogov RNRMU; General Practitioner, Cardiologist, Functional Diagnostics Doctor, Ultrasound Diagnostics Doctor, CCH No. 31 named after Academician G.M. Savelyeva.

1, Ostrovitianov St., Moscow, 117997; 42, Bldg. 2, Lobachevsky St., Moscow, 119415; Researcher ID: N-6856-2016

elenaresnik@gmail.com

Городская поликлиника № 11; Российский национальный исследовательский медицинский университет имени Н.И. ПироговаРоссияCity Polyclinic No. 11; Pirogov Russian National Research Medical UniversityRussian Federation

Гродненский государственный медицинский университетБеларусьGrodno State Medical UniversityBelarus

Российский национальный исследовательский медицинский университет имени Н.И. Пирогова; Городская клиническая больница №31 имени академика Г.М. СавельевойРоссияPirogov Russian National Research Medical University; City Clinical Hospital No. 31 named after Academician G.M. SavelyevaRussian Federation

2023

22102023

016138147

2023

Змитрукевич А.С., Мамедова А.Е., Резник Е.В.

Zmitrukevich A.S., Mamedova A.E., Reznik E.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-sovet.pro/jour/article/view/7810

Пандемия COVID-19 стала глобальным кризисом беспрецедентного уровня для всего человечества. Весь процесс изучения заболевания (этиопатогенез, диагностика, лечение, профилактика, прогноз) был непростым, т. к. COVID-19 – это относительно новая нозология, с которой мир никогда не сталкивался. Сердечно-сосудистые осложнения при COVID-19 играют немаловажную роль в прогнозе заболеваемости и смертности. По мере распространения пандемии COVID-19 появляется все больше пациентов с нарушениями ритма сердца, артериальной гипертензией и прочими сердечно-сосудистыми осложнениями после перенесенной коронавирусной инфекции. Это может быть связано с воздействием коронавируса тяжелого острого респираторного синдрома (SARS-CoV-2) на дыхательную, сердечно-сосудистую и прочие системы, а также с развитием воспаления. Во время пандемии COVID-19 стало больше пациентов с аритмиями. По некоторым данным, риск развития аритмий при COVID-19 у госпитализированных пациентов варьирует от 7,57 до 17,97%. Основными причинами аритмии в контексте COVID-19 являются гипоксия (острый респираторный дистресс-синдром, тромбоэмболия легочной артерии, воздействие SARS-CoV-2 на хеморецепторы), миокардит (прямое и косвенное воздействие SARS-CoV-2 на миокард), электролитный дисбаланс, вегетативная дисфункция, используемые при COVID-19 кардиотоксичные препараты. Зачастую причин может быть несколько, и разобраться, какая именно стала основной для каждого пациента, достаточно трудно. В этом обзоре основное внимание уделяется потенциальным механизмам развития нарушений сердечного ритма у пациентов с COVID-19. Кардиологи, терапевты и врачи общей практики должны знать об особенностях сердечнососудистых осложнений при ведении пациентов с COVID-19, а также диспансеризации населения.

The COVID-19 pandemic has become a global crisis of unprecedented level for all mankind. The whole process of studying the disease (etiopathogenesis, diagnosis, treatment, prevention, prognosis) was not easy, because COVID-19 is a relatively new nosology that the world has never encountered. Cardiovascular complications in COVID-19 play an important role in the prognosis of morbidity and mortality. As the COVID-19 pandemic spreads, more and more patients with cardiac arrhythmias, arterial hypertension and other cardiovascular complications appear. This may be due to the impact of the SARS-CoV-2 virus on the respiratory, cardiovascular and other systems, as well as the development of inflammation. During the COVID-19 pandemic, there were more patients with arrhythmias. According to some data, the risk of arrhythmias in COVID-19 in hospitalized patients varies from 7.57% to 17.97%. The main causes of arrhythmia in the context of COVID-19 are hypoxia (acute respiratory distress syndrome, pulmonary embolism, the effect of SARS-CoV-2 on chemoreceptors), myocarditis (direct and indirect effects of SARS-CoV-2 on the myocardium), electrolyte imbalance, autonomic dysfunction, cardiotoxic drugs used in COVID-19. There can often be several reasons, and it is quite difficult to figure out which one has become the main one for each patient. This review focuses on the potential mechanisms for the development of cardiac arrhythmias in patients with COVID-19. Cardiologists, therapists and family medicine physicians should be aware of cardiovascular complications in the management of patients with COVID-19, and the prophylactic medical examination of the population.

вегетативная дисфункциягипоксиямиокардитэлектролитыпостковидный синдромтромбоэмболия

autonomic dysfunctionhypoxiamyocarditiselectrolytespost-COVID syndromethromboembolism

При написании данной статьи авторы не использовали никаких грантов и прочих источников финансирования. Авторы заявляют, что у них нет конкурирующих интересов. Обзор составлен для публичного ознакомления

The authors received no grant or other support from any funding agency to write this article. The authors declare that they have no competing interests. The review has been prepared to be available to the public

References1

Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. https://doi.org/10.1016/B978-0-12-385885-6.00009-2.

Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe.2015;18(4):398–401. https://doi.org/10.1016/j.chom.2015.09.013.

Ji W, Wang W, Zhao X, Zai J, Li X. Cross‐species transmission of the newly identified coronavirus 2019‐nCoV. J Med Virol. 2020;92(4):433–440. https://doi.org/10.1002/jmv.25682.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.

Zmitrukevich AS. Cardiovascular Changes in COVID19. Act Scie Medic. 2022;6(Special Issue 2):32–39. https://doi.org/10.31080/ASMS.2022.S02.0007.

Змитрукевич АС, Мамедова АЕ. Артериальная гипертензия при COVID-19. Клиническая медицина. 2023;101(1):26–31. https://doi.org/10.30629/0023-2149-2023-101-1-26-31.

Zmitrukevich АS, Mamedova AE. Arterial hypertension in COVID-19. Clinical Medicine (Russian Journal). 2023;101(1):26–31. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-1-26-31.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585.

Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439–1444. https://doi.org/10.1016/j.hrthm.2020.06.016.

Sala S, Peretto G, De Luca G, Farina N, Campochiaro C, Tresoldi M et al. Low prevalence of arrhythmias in clinically stable COVID‐19 patients. Pacing Clin Electrophysiol. 2020;43(8):891–893. https://doi.org/10.1111/pace.13987.

Mountantonakis SE, Saleh M, Fishbein J, Gandomi A, Lesser M, Chelico J et al. Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm. 2021;18(4):501–507. https://doi.org/10.1016/j.hrthm.2021.01.018.

Wen W, Zhang H, Zhou M, Cheng Y, Chen J, Wang M, Feng Z. Arrhythmia in patients with severe coronavirus disease (COVID-19): a meta-analysis. Eur Rev Med Pharmacol Sci. 2020;24(21):11395–11401. https://doi.org/10.26355/eurrev_202011_23632.

Liao SC, Shao SC, Cheng CW, Chen YC, Hung MJ. Incidence rate and clinical impacts of arrhythmia following COVID-19: a systematic review and meta-analysis of 17,435 patients. Crit Care. 2020;24(1):690. https://doi.org/10.1186/s13054-020-03368-6.

Лобанов СА, Шишкин ЕВ, Кузнецова НО, Малагина АА, Хисматуллина ЗР, Насырова ЕВ и др. Влияние гипоксии на организм. Вестник Башкирского государственного педагогического университета им. М. Акмуллы. 2017;(2):12–27. Режим доступа: https://elibrary.ru/item.asp?id=29896278&ysclid=lmonvkg038689167109.

Lobanov SA, Shishkin EV, Kuznetsova NO, Malagina AA, Hismatullina ZP, Nasyrova EV et al. The effect of hypoxia on the body. Bulletin of the Akmulla Bashkir State Pedagogical University. 2017;(2):12–27. (In Russ.) Available at: https://elibrary.ru/item.asp?id=29896278&ysclid=lmonvkg038689167109.

Le Page LM, Rider OJ, Lewis AJ, Noden V, Kerr M, Giles L et al. Assessing the effect of hypoxia on cardiac metabolism using hyperpolarized 13C magnetic resonance spectroscopy. NMR Biomed. 2019;32(7):e4099. https://doi.org/10.1002/nbm.4099.

Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol (1985). 1989;67(5):2095–2100. https://doi.org/10.1152/jappl.1989.67.5.2095.

Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020;95(6):1138–1147. https://doi.org/10.1016/j.mayocp.2020.04.006.

Chang JC. Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis. Clin Appl Thromb Hemost. 2019;25:1076029619887437. https://doi.org/10.1177/1076029619887437.

Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on “Two-Path Unifying Theory” of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag. 2021;17:273–298. https://doi.org/10.2147/VHRM. S299357.

Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48(9):1358–1364. https://doi.org/10.1097/CCM.0000000000004458.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. https://doi.org/10.1007/s00134-020-05991-x.

Cooke JP, Connor JH, Jain A. Acute and chronic cardiovascular manifestations of COVID-19: role for endotheliopathy. Methodist Debakey Cardiovasc J. 2021;17(5):53. https://doi.org/10.14797/mdcvj.1044.

Marvi TK, Stubblefield WB, Tillman BF, Tenforde MW, Patel MM, Lindsell CJ et al. Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19. Crit Care Explor. 2022;4(1):e0618. https://doi.org/10.1097/CCE.0000000000000618.

Fraga-Silva RA, Pinheiro SVB, Gonçalves ACC, Alenina N, Bader M, Santos RAS. The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Mol Med. 2008;14(1):28–35. https://doi.org/10.2119/2007-00073.Fraga-Silva.

Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14–20. https://doi.org/10.1016/j.ejim.2020.04.037.

Klok FA, Kruip MJ, Van der Meer NJ, Arbous MS, Gommers DAMPJ, Kant KM et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. https://doi.org/10.1016/j.thromres.2020.04.013.

Grimnes G, Isaksen T, Tichelaar YIGV, Brækkan SK, Hansen JB. Acute infection as a trigger for incident venous thromboembolism: results from a population‐based case‐crossover study. Res Pract Thromb Haemost. 2018;2(1):85-92. https://doi.org/10.1002/rth2.12065.

Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356–360. https://doi.org/10.1164/rccm.202006-2157CP.

Fung ML. Expressions of angiotensin and cytokine receptors in the paracrine signaling of the carotid body in hypoxia and sleep apnea. Respir Physiol Neurobiol. 2015;209:6–12. https://doi.org/10.1016/j.resp.2014.09.014.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374. https://doi.org/10.1007/s11427-020-1643-8.

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7775. https://doi.org/10.1128/JVI.00737-08.

Elming H, Brendorp B, Køber L, Sahebzadah N, Torp-Petersen C. QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev. 2002;6(3):289–294. https://doi.org/10.1023/A:1016345412555.

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352–2371. https://doi.org/10.1016/j.jacc.2020.03.031.

Гетман СИ, Чепель АИ, Тегза ВЮ. Диагностика миокардита в условиях пандемии COVID-19. Международный научно-исследовательский журнал. 2021;9–2(111):18–23. https://doi.org/10.23670/IRJ.2021.9.111.037.

Getman SI, Chepel AI, Tegza VYu. Diagnosis of myocarditis in the context of the COVID-19 PANDEMIC. International Research Journal. 2021;9–2(111): 18–23. (In Russ.) https://doi.org/10.23670/IRJ.2021.9.111.037.

Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020;526(1):165–169. https://doi.org/10.1016/j.bbrc.2020.03.047.

Vukusic K, Thorsell A, Muslimovic A, Jonsson M, Dellgren G, Lindahl A et al. Overexpression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 in cardiomyocytes of failing hearts. Sci Rep. 2022;12(1):1–9. https://doi.org/10.1038/s41598-022-04956-y.

Sharma A, Garcia Jr G, Wang Y, Plummer JT, Morizono K, Arumugaswami V, Svendsen CN. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. bioRxiv [Preprint]. 2020;1(4):100052. https://doi.org/10.1016/j.xcrm.2020.100052.

Wong CK, Luk HK, Lai WH, Lau YM, Zhang RR, Wong ACP et al. Humaninduced pluripotent stem cell-derived cardiomyocytes platform to study SARS-CoV-2 related myocardial injury. Circ J. 2020;84(11):2027–2031. https://doi.org/10.1253/circj.CJ-20-0881.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5.

Basso C, Leone O, Rizzo S, Gaspari MD, van der Wal AC, Aubry MC et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827–3835. https://doi.org/10.1093/eurheartj/ehaa664.

Gauchotte G, Venard V, Segondy M, Cadoz C, Esposito-Fava A, Barraud D, Louis G. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study. Int J Legal Med. 2021;135(2):577–581. https://doi.org/10.1007/s00414-020-02500-z.

Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(3):314–325. https://doi.org/10.1016/j.jacc.2020.11.031.

Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281–1285. https://doi.org/10.1001/jamacardio.2020.3551.

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–824. https://doi.org/10.1001/jamacardio.2020.1096

Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861–1862. https://doi.org/10.1093/eurheartj/ehaa286.

Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. https://doi.org/10.3389/fimmu.2019.00119.

Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. https://doi.org/10.1126/science.abb8925.

Chau VQ, Giustino G, Mahmood K, Oliveros E, Neibart E, Oloomi M et al. Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Heart Fail. 2020;13(10):e007485. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007485.

Hékimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J, Bréchot N et al. Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. Chest. 2021;159(2):657–662. https://doi.org/10.1016/j.chest.2020.08.2099.

Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J et al. COVID-19–associated multisystem inflammatory syndrome in children – United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074. https://doi.org/10.15585/mmwr.mm6932e2.

Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection – United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450. https://doi.org/10.15585/mmwr.mm6940e1.

Vannella KM, Oguz C, Stein SR, Pittaluga S, Dikoglu E, Kanwal A et al. Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case. Front Immunol. 2021;12:779026. https://doi.org/10.3389/fimmu.2021.779026.

Bajdechi M, Vlad ND, Dumitrascu M, Mocanu E, Dumitru IM, Cernat RC, Rugină S. Bacterial endocarditis masked by COVID-19: A case report. Exp Ther Med. 2022;23(2):1–4. https://doi.org/10.3892/etm.2021.11109.

Ramos-Martínez A, Fernández-Cruz A, Domínguez F, Forteza A, Cobo M, Sánchez-Romero I, Asensio A. Hospital-acquired infective endocarditis during COVID-19 pandemic. Infect Prev Pract. 2020;2(3):100080. https://doi.org/10.1016/j.infpip.2020.100080.

Hayes DE, Rhee DW, Hisamoto K, Smith D, Ro R, Vainrib AF et al. Two cases of acute endocarditis misdiagnosed as COVID‐19 infection. Echocardiography. 2021;38(5):798–804. https://doi.org/10.1111/echo.15021.

Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198–209. https://doi.org/10.1111/his.14134.

Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004;27(2):153–160. https://doi.org/10.1016/j.jemermed.2004.04.006.

Chen D, Li X, Song Q, Hu C, Su F, Dai J et al. Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19). MedRxiv. 2020.02.27.20028530. https://doi.org/10.1101/2020.02.27.20028530.

Alnafiey MO, Alangari AM, Alarifi AM, Abushara A. Persistent Hypokalemia post SARS-coV-2 infection, is it a life-long complication? Case report. Ann Med Surg (Lond). 2021;62:358–361. https://doi.org/10.1016/j.amsu.2021.01.049.

Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262–265. https://doi.org/10.1177/0004563220922255.

Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. https://doi.org/10.1136/bmj.n136.

Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18(4):508–509. https://doi.org/10.1016/j.hrthm.2020.12.007.

Scala I, Bellavia S, Luigetti M, Brunetti V, Broccolini A, Gabrielli M et al. Autonomic dysfunction in non-critically ill COVID-19 patients during the acute phase of disease: an observational, cross-sectional study. Neurol Sci. 2022;43:4635–4643. https://doi.org/10.1007/s10072-022-06136-2.

The authors declare that there are no conflicts of interest present.